Design of potent fluoro-substituted chalcones as antimicrobial agents. 2017

Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
a Tercan Vocational High School, Erzincan University , Erzincan , Turkey.

Owing to ever-increasing bacterial and fungal drug resistance, we attempted to develop novel antitubercular and antimicrobial agents. For this purpose, we developed some new fluorine-substituted chalcone analogs (3, 4, 9-15, and 20-23) using a structure-activity relationship approach. Target compounds were evaluated for their antitubercular efficacy against Mycobacterium tuberculosis H37Rv and antimicrobial activity against five common pathogenic bacterial and three common fungal strains. Three derivatives (3, 9, and 10) displayed significant antitubercular activity with IC50 values of ≤16,760. Compounds derived from trimethoxy substituent scaffolds with monofluoro substitution on the B ring of the chalcone structure exhibited superior inhibition activity compared to corresponding hydroxy analogs. In terms of antimicrobial activity, most compounds (3, 9, 12-14, and 23) exhibited moderate to potent activity against the bacteria, and the antifungal activities of compounds 3, 13, 15, 20, and 22 were comparable to those of reference drugs ampicillin and fluconazole.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D047188 Chalcones Derivatives of CHALCONE that are important intermediates in the formation of FLAVONOIDS with anti-fungal, anti-bacterial, anti-inflammatory, and anti-tumor properties. 1,3-Diphenyl-propanediones,1,3-Diphenyl-propenones,1,3-Diphenylpropanediones,1,3-Diphenylpropenones,Chalconoids,1,3 Diphenyl propanediones,1,3 Diphenyl propenones,1,3 Diphenylpropanediones,1,3 Diphenylpropenones

Related Publications

Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
October 2012, Bioorganic & medicinal chemistry letters,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
May 2011, Bioorganic & medicinal chemistry,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
January 2012, Natural product research,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
December 2020, Drug development research,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
November 2013, European journal of medicinal chemistry,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
February 2010, European journal of medicinal chemistry,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
October 2013, European journal of medicinal chemistry,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
May 2022, Bioorganic chemistry,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
January 2016, Combinatorial chemistry & high throughput screening,
Serdar Burmaoglu, and Oztekin Algul, and Arzu Gobek, and Derya Aktas Anil, and Mahmut Ulger, and Busra Gul Erturk, and Engin Kaplan, and Aylin Dogen, and Gönül Aslan
January 2020, Theranostics,
Copied contents to your clipboard!